AURA
insider transactionsAura Biosciences, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
-6.9M
0 buy · 6.9M sell
Net value · 90d
-$39.2M
$0 in · $39.2M out
Sentiment · 90d
Net selling
0% buying · 100% selling
Open-market trades · 90d
3
0 buy · 6.9M sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
Anthony S Gibney KEY
Chief Financial and Business …
$82.3K
12.8K sh · $6.42
Own -5%
-
Grant·A
Director
$0
30.0K sh
Own New
-
Grant·A
Director
$0
15.0K sh
Own +71%
-
Grant·A
Director
$0
30.0K sh
Own New
-
Grant·A
Director
$0
15.0K sh
Own +64%
-
Grant·A
Director
$0
30.0K sh
Own New
-
Grant·A
Director
$0
15.0K sh
Own +8%
-
Grant·A
Director
$0
30.0K sh
Own New
-
Grant·A
Director
$0
15.0K sh
Own +64%
-
Grant·A
Chief Executive Officer and P…
$0
2.2M sh
Own New
-
Grant·A
Chief Executive Officer and P…
$0
553.8K sh
Own +92%
-
Grant·A
Chief Executive Officer and P…
$0
600.1K sh
Own New
-
Sell·S
$39.0M
6.9M sh · $5.64
Own -100%
-
Sell·S
Chief Legal Officer and Secre…
$82.4K
11.7K sh · $7.02
Own -5%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 16, 2026 | Anthony S Gibney KEY | Sell S | 12.8K | $82.3K |
| Jun 11, 2026 | Teresa Marie Bitetti | Grant A | 30.0K | $0 |
| Jun 11, 2026 | Teresa Marie Bitetti | Grant A | 15.0K | $0 |
| Jun 11, 2026 | Sapna Srivastava | Grant A | 30.0K | $0 |
| Jun 11, 2026 | Sapna Srivastava | Grant A | 15.0K | $0 |
| Jun 11, 2026 | David Michael Johnson | Grant A | 30.0K | $0 |
| Jun 11, 2026 | David Michael Johnson | Grant A | 15.0K | $0 |
| Jun 11, 2026 | Antony C. Mattessich | Grant A | 30.0K | $0 |
| Jun 11, 2026 | Antony C. Mattessich | Grant A | 15.0K | $0 |
| May 19, 2026 | Natalie C. Holles KEY | Grant A | 2.2M | $0 |
| May 19, 2026 | Natalie C. Holles KEY | Grant A | 553.8K | $0 |
| May 19, 2026 | Natalie C. Holles KEY | Grant A | 600.1K | $0 |
| May 7, 2026 | Matrix Capital Management Company, LP / David E. Goel | Sell S | 6.9M | $39.0M |
| Apr 16, 2026 | Conor Kilroy | Sell S | 11.7K | $82.4K |
About AURA insider trading
This page tracks insider transactions for Aura Biosciences, Inc. (AURA) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.